Navidea Biopharma (NAVB) Announces Adam Cutler to Board
Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) today announced the appointment of Adam Cutler to the Company’s board of directors, effective December ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)